ATLANTA, March 26, 2012 /PRNewswire/ -- Beginning today, Northside Hospital and Atlanta Perinatal Consultants announce the availability of an affordable, safe and advanced screening test for common fetal trisomies, such as trisomy 21 that causes Down syndrome and trisomy 18 that causes Edwards syndrome.
The Harmony Prenatal Test, developed and offered by Ariosa Diagnostics utilizes a novel testing platform to analyze DNA in maternal blood so as to provide more accurate and personalized risk assessments for patients compared to current prenatal screening options. Published data in the American Journal of Obstetrics and Gynecology as well as Prenatal Diagnosis highlight the enhanced performance for trisomy 21 and 18 detection. The test is available to women of at least 10 weeks gestational age and is performed exclusively by Ariosa Diagnostics.
"The Harmony Prenatal Test will transform the way we test for common fetal trisomies in all pregnant women," explains Dr. Kevin J. Gomez, geneticist and maternal fetal medicine specialist of Atlanta Perinatal Consultants. "By combining the Harmony Prenatal Test with detailed ultrasound examination, we can offer superior clinical care to our patients compared to current prenatal screening options. As with any new technology, it should be introduced responsibly into clinical practice. We are excited to be the first practice in the Southeast to offer this advance in prenatal testing."
Atlanta Perinatal Consultants is a specialty provider for pregnant women at Northside Hospital. Northside Hospital, an undisputed leader in maternity services, delivers more than 17,000 babies a year, more than any other hospital in the United States. Northside strives to deliver the most advanced and highest quality care to its patients, and has been recognized for service excellence for a third consecutive year under the J.D. Power and Associates Distinguished Hospital Prog